AJP - Endocrinology and Metabolism, Vol 262, Issue 5 E736-E740, Copyright © 1992 by American Physiological Society

ARTICLES

Increased islet blood flow in obese rats: role of the autonomic nervous system

N. Atef, A. Ktorza, L. Picon and L. Penicaud
Laboratoire de Physiopathologie de la Nutrition, Centre National de la Recherche Scientifique, Unite de Recherche Associee 307, Universite Paris VII, France.

Hyperinsulinemia, a main feature of both human and animal obesity, has been demonstrated to be due to both an increased sensitivity to nutrient secretagogues and an impairment of the nervous regulation of insulin secretion. Recent studies have shown that pancreatic islet blood flow increases under conditions associated with an enhanced insulin secretion. The aim of this study was to determine whether or not changes in islet blood flow are present in hyperinsulinemic obese rats. Using the nonradioactive microsphere technique, we were able to show a significantly higher islet blood flow in obese rats either of the Zucker strain or Wistar rats after lesion of the ventromedial hypothalamus than in their respective lean controls. Subdiaphragmatic vagotomy had no significant effect on basal islet blood flow of lean rats, whereas it decreased significantly that of obese Zucker rats. Conversely, clonidine, an alpha 2-adrenergic agonist, induced a higher decrease of islet blood flow in obese than in lean Zucker rats. The injection of an intravenous bolus of glucose (375 mg/kg iv) increased significantly more islet blood flow in obese than in lean Zucker rats. It is concluded that obese rats present an increased pancreatic islet blood flow, which may result, at least in part, from exaggerated parasympathetic activity and lower than normal sympathetic activity. This could participate in the hyperinsulinemia observed in these rats.

This article has been cited by other articles:

				R. C. Reddy, Y. Hao, S.-H. Lee, S. R. Gangireddy, C. Owyang, and M. J. DiMagno Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS(-/-) mice: therapy for exocrine pancreatic disorders? Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G112 - G120. [Abstract] [Full Text] [PDF]

				C. Anneren, M. Welsh, and L. Jansson Glucose intolerance and reduced islet blood flow in transgenic mice expressing the FRK tyrosine kinase under the control of the rat insulin promoter Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1183 - E1190. [Abstract] [Full Text] [PDF]

				M. Iwase, Y. Uchizono, K. Tashiro, D. Goto, and M. Iida Islet Hyperperfusion During Prediabetic Phase in OLETF Rats, a Model of Type 2 Diabetes Diabetes, August 1, 2002; 51(8): 2530 - 2535. [Abstract] [Full Text] [PDF]

				A. M. Svensson, C.-G. Ostenson, and L. Jansson Age-induced changes in pancreatic islet blood flow: evidence for an impaired regulation in diabetic GK rats Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1139 - E1144. [Abstract] [Full Text] [PDF]

				P.-O. Carlsson, A. Andersson, and L. Jansson Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E594 - E601. [Abstract] [Full Text] [PDF]

				Q. Li, M. J. Sullivan, W. E. Dale, E. M. Hasser, E. H. Blaine, and J. T. Cunningham Fos-Like Immunoreactivity in the Medulla after Acute and Chronic Angiotensin II Infusion J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1165 - 1173. [Abstract] [Full Text]